Previous close | 28.07 |
Open | 28.53 |
Bid | 29.05 x 30000 |
Ask | 29.26 x 30000 |
Day's range | 28.42 - 28.53 |
52-week range | 24.08 - 36.25 |
Volume | |
Avg. volume | 5 |
Market cap | 3.927B |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.03 |
Earnings date | N/A |
Forward dividend & yield | 1.01 (3.60%) |
Ex-dividend date | 07 Mar 2024 |
1y target est | 51.00 |
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial results on Tuesday, May 7th, 2024, and host a conference call beginning at 8:30 A.M. (EDT).
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio had a 5.7% gain in the first quarter compared to an 8.2% return in the Russell Midcap Value Index. The Strategy underperformed in Financials and Industrials due […]
Pharma company Perrigo plans to spread the word about Opill at the WNBA draft.